Assay Depot announces partnership with AstraZeneca
Assay Depot Inc., the world's largest online marketplace for pharmaceutical research services, has today announced it has launched a virtual research laboratory, developed in partnership with AstraZeneca.
The private virtual laboratory, titled Research Exchange, is a vendor relationship management (VRM) system, which gives researchers easy access to a distributed network of thousands of research service providers, located both inside and outside the company. Researchers will be able to access the laboratory online, either using a computer, tablet or mobile device.
“We brought together features of today’s favorite consumer websites to create a virtual laboratory that empowers scientists. A small group of talented scientists can now run an entire drug discovery program, from concept to clinic, from a laptop computer.”
Kevin Lustig, Assay Depot’s CEO.
Research Exchange will enable complete transparency across global research operations, while still retaining local control over research sourcing decisions. Serving as an all-in-one platform, the laboratory will benefit the entire chain of pharmaceutical stakeholders, including discovery research, supply chain and consumer health.
“By connecting our internal and external science, the virtual laboratory platform is creating a new approach for our scientists to run experiments with an optimal balance of speed, quality, and cost. We look forward to assessing how the virtual laboratory platform impacts and accelerates productivity in the R&,D pipeline.”
Mike Snowden, Vice President, Discovery Sciences, AstraZeneca.
Assay Depot Partners with AstraZeneca to Launch Virtual Research Laboratory (Business Wire)